With the pharmaceutical industry in the USA predicted to rise to $9.7 billion by 2027, quality control will be key to maintaining public safety for pharmaceutical use. Beyond Innovation's Anthony Lacavera sits down with Valisure's CEO, David Light, to discover how Valisure batch-tests medications to ensure therapeutic effectiveness, predictable performance, and safety.
Check out the interview via YouTube from Season 3 that aired on Bloomberg TV.
With the pharmaceutical industry in the USA predicted to rise to $9.7 billion by 2027, quality control will be key to maintaining public safety for pharmaceutical use. Beyond Innovation's Anthony Lacavera sits down with Valisure's CEO, David Light, to discover how Valisure batch-tests medications to ensure therapeutic effectiveness, predictable performance, and safety.
Check out the interview via YouTube from Season 3 that aired on Bloomberg TV.
With the pharmaceutical industry in the USA predicted to rise to $9.7 billion by 2027, quality control will be key to maintaining public safety for pharmaceutical use. Beyond Innovation's Anthony Lacavera sits down with Valisure's CEO, David Light, to discover how Valisure batch-tests medications to ensure therapeutic effectiveness, predictable performance, and safety.
Check out the interview via YouTube from Season 3 that aired on Bloomberg TV.
With the pharmaceutical industry in the USA predicted to rise to $9.7 billion by 2027, quality control will be key to maintaining public safety for pharmaceutical use. Beyond Innovation's Anthony Lacavera sits down with Valisure's CEO, David Light, to discover how Valisure batch-tests medications to ensure therapeutic effectiveness, predictable performance, and safety.
Check out the interview via YouTube from Season 3 that aired on Bloomberg TV.
